Observational studyHuman vaccines & immunotherapeutics2022

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine.

Maria E Sundaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.